Long-term tracking of plasma phospholipid fatty acid concentrations and their correlation with the dietary intake of marine foods in newly diagnosed diabetic patients: Results from a follow-up of the HUNT Study, Norway

British Journal of Nutrition

Volumn 109, Issue 6, 2013, Pages 1123-1134

  Lindberg, Morten ^a,b,c   Midthjell, Kristian ^b   Bjerve, Kristian S ^a,b  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c VESTFOLD HOSPITAL TRUST   (Norway)

Author keywords

Biological variation; Fish oil; Long term tracking; Type 2 diabetes

Indexed keywords

COD LIVER OIL; DOCOSAHEXAENOIC ACID; FATTY ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID;

ACCURACY; ADULT; AGED; ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; FATTY ACID BLOOD LEVEL; FEMALE; FISH; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORWAY; REFERENCE VALUE; SEA FOOD; SELF REPORT;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; DIABETES MELLITUS, TYPE 2; DIET; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; FISHES; HUMANS; MALE; MIDDLE AGED; NORWAY; PHOSPHOLIPIDS; SEAFOOD;

EID: 84875018649     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114512002759     Document Type: Article

References (43)

1. Ma J, Folsom AR, Shahar E, et al. (1995) Plasma fatty acidcomposition as an indicator of habitual dietary fat intake inmiddle-aged adults. The Atherosclerosis Risk in Communities(ARIC) Study Investigators. Am J Clin Nutr 62,564-571.
2. Bønaa KH, Bjerve KS & Nordøy A (1992) Habitual fishconsumption, plasma phospholipid fatty acids, and serumlipids: the Tromsø Study. Am J Clin Nutr 55, 1126-1134.
3. Baylin A & Campos H (2006) The use of fatty acidbiomarkers to reflect dietary intake. Curr Opin Lipidol 17,22-27. (Pubitemid 43100299)
4. Miettinen TA, Naukkarinen V, Huttunen JK, et al. (1982)Fatty-acid composition of serum lipids predicts myocardialinfarction. Br Med J (Clin Res Ed) 285, 993-996. (Pubitemid 12018483)
5. Albert CM, Campos H, Stampfer MJ, et al. (2002) Blood levelsof long-chain n-3 fatty acids and the risk of sudden death.N Engl J Med 346, 1113-1118. (Pubitemid 34984601)
6. Erkkila AT, Lehto S, Pyörälä K, et al. (2003) n-3 Fatty acidsand 5-y risks of death and cardiovascular disease events inpatients with coronary artery disease. Am J Clin Nutr 78,65-71. (Pubitemid 39655249)
7. Lindberg M, Saltvedt I, Sletvold O, et al. (2008) Long-chainn-3 fatty acids and mortality in elderly patients. Am J ClinNutr 88, 722-729.
8. Moilanen T, Rasanen L, Viikari J, et al. (1992) Tracking ofserum fatty acid composition: a 6-year follow-up study inFinnish youths. Am J Epidemiol 136, 1487-1492. (Pubitemid 23054673)
9. Ma J, Folsom AR, Eckfeldt JH, et al. (1995) Short-andlong-term repeatability of fatty acid composition ofhuman plasma phospholipids and cholesterol esters.The Atherosclerosis Risk in Communities (ARIC) StudyInvestigators. Am J Clin Nutr 62, 572-578.
10. Zeleniuch-Jacquotte A, Chajes V, Van Kappel AL, et al. (2000)Reliability of fatty acid composition in human serumphospholipids. Eur J Clin Nutr 54, 367-372. (Pubitemid 30261386)
11. Guerra A, Demmelmair H, Toschke AM, et al. (2007)Three-year tracking of fatty acid composition of plasmaphospholipids in healthy children. Ann Nutr Metab 51,433-438. (Pubitemid 350212733)
12. Corpeleijn E, Feskens EJ, Jansen EH, et al. (2006)Improvements in glucose tolerance and insulin sensitivityafter lifestyle intervention are related to changes in serumfatty acid profile and desaturase activities: the SLIM study.Diabetologia 49, 2392-2401. (Pubitemid 44359101)
13. Montanaro MA, Gonzalez MS, Bernasconi AM, et al. (2007)Role of liver X receptor, insulin and peroxisome proliferatoractivated receptor alpha on in vivo desaturase modulationof unsaturated fatty acid biosynthesis. Lipids 42, 197-210. (Pubitemid 46651415)
14. Oh da Y, Talukdar S, Bae EJ, et al. (2010) GPR120 isan omega-3 fatty acid receptor mediating potent antiinflammatoryand insulin-sensitizing effects. Cell 142,687-698.
15. Claudi T, Midthjell K, Holmen J, et al. (2000) Cardiovasculardisease and risk factors in persons with type 2 diabetes diagnosedin a large population screening: the Nord-TrøndelagDiabetes Study, Norway. J Intern Med 248, 492-500. (Pubitemid 32052005)
16. WHO (1980) WHO Expert Committee on Diabetes Mellitus:second report. World Health Organ Tech Rep Ser 646, 1-80.
17. Dale AC, Nilsen TI, Vatten L, et al. (2007) Diabetes mellitusand risk of fatal ischaemic heart disease by gender: 18years follow-up of 74,914 individuals in the HUNT 1 Study.Eur Heart J 28, 2924-2929. (Pubitemid 350233026)
18. Dale AC, Vatten LJ, Nilsen TI, et al. (2008) Secular decline inmortality from coronary heart disease in adults with diabetesmellitus: cohort study. BMJ 337, a236.
19. Dale AC, Midthjell K, Nilsen TI, et al. (2009) Glycaemic controlin newly diagnosed diabetes patients and mortality fromischaemic heart disease: 20 years follow-up of the HUNTstudy in Norway. Eur Heart J 30, 1372-1377.
20. Bjerve KS, Daae LN & Bremer J (1974) The selective loss oflysophospholipids in some commonly used lipid-extractionprocedures. Anal Biochem 58, 238-245.
21. Bjerve KS, Fischer S & Alme K (1987) Alpha-linolenic aciddeficiency in man: effect of ethyl linolenate on plasmaand erythrocyte fatty acid composition and biosynthesis ofprostanoids. Am J Clin Nutr 46, 570-576. (Pubitemid 18005719)
22. Slagsvold JE, Thorstensen K, Kvitland M, et al. (2009) Fattyacid desaturase expression in human leucocytes correlateswith plasma phospholipid fatty acid status. Scand J ClinLab Invest 69, 496-504.
23. Peter A, Cegan A, Wagner S, et al. (2009) Hepatic lipidcomposition and stearoyl-coenzyme A desaturase 1 mRNAexpression can be estimated from plasma VLDL fatty acidratios. Clin Chem 55, 2113-2120.
24. Harris WS (2008) The omega-3 index as a risk factor forcoronary heart disease. Am J Clin Nutr 87, 1997S-2002S. (Pubitemid 351872681)
25. Harris WS & Von Schacky C (2004) The Omega-3 Index: anew risk factor for death from coronary heart disease? PrevMed 39, 212-220. (Pubitemid 38797975)
26. Fraser CG (2001) Biological Variation: From Principles toPractice. Washington, DC: AACC Press.
27. Burtis CA, Ashwood ER, Tietz NW, et al. (2006) TietzTextbook of Clinical Chemistry and Molecular Diagnostics.Philadelphia, PA: Elsevier Saunders.
28. Tiao JY, Semmens JB, Masarei JR, et al. (2002) The effect ofage on serum creatinine levels in an aging population:relevance to vascular surgery. Cardiovasc Surg 10, 445-451.
29. NORIP (2009) Nordic Reference Interval Project. http://www.furst.no/ norip/(accessed 16 October 2011).
30. de Klerk NH, English DR & Armstrong BK (1989) A review ofthe effects of random measurement error on relative riskestimates in epidemiological studies. Int J Epidemiol 18,705-712. (Pubitemid 19268621)
31. Landis JR & Koch GG (1977) The measurement of observeragreement for categorical data. Biometrics 33, 159-174.
32. Kaitosaari T, Simell O, Viikari J, et al. (2009) Tracking anddeterminants of LDL particle size in healthy children from7 to 11 years of age: the STRIP Study. Eur J Pediatr 168,531-539.
33. Christie WW (1987) High-performance Liquid Chromatographyand Lipids-A Practical Guide, pp. 72-73. Oxford:Pergamon Press.
34. Rouser G, Kritchevsky G, Yamamoto A, et al. (1969) Methodsin Enzymology, pp. 289-290 [SP Colowick and NO Kaplan,editors]. New York: Academic Press.
35. Baylin A, Kim MK, Donovan-Palmer A, et al. (2005) Fastingwhole blood as a biomarker of essential fatty acid intakein epidemiologic studies: comparison with adipose tissueand plasma. Am J Epidemiol 162, 373-381. (Pubitemid 41389719)
36. Patel PS, Sharp SJ, Jansen E, et al. (2010) Fatty acidsmeasured in plasma and erythrocyte-membrane phospholipidsand derived by food-frequency questionnaire and therisk of new-onset type 2 diabetes: a pilot study in the EuropeanProspective Investigation into Cancer and Nutrition(EPIC)-Norfolk cohort. Am J Clin Nutr 92, 1214-1222.
37. Katan MB, Deslypere JP, van Birgelen AP, et al. (1997)Kinetics of the incorporation of dietary fatty acids intoserum cholesteryl esters, erythrocyte membranes, and adiposetissue: an 18-month controlled study. J Lipid Res 38,2012-2022. (Pubitemid 27468010)
38. Bradbury KE, Skeaff CM, Green TJ, et al. (2010) The serumfatty acids myristic acid and linoleic acid are better predictorsof serum cholesterol concentrations when measured as molecularpercentages rather than as absolute concentrations.Am J Clin Nutr 91, 398-405.
39. Harris WS & Thomas RM (2010) Biological variability ofblood omega-3 biomarkers. Clin Biochem 43, 338-340.
40. Welch AA, Shakya-Shrestha S, Lentjes MA, et al. (2010) Dietaryintake and status of n-3 polyunsaturated fatty acids in apopulation of fish-eating and non-fish-eating meat-eaters,vegetarians, and vegans and the precursor-product ratio of{alpha}-linolenic acid to long-chain n-3 polyunsaturatedfatty acids: results from the EPIC-Norfolk cohort. Am J ClinNutr 92, 1040-1051.
41. Petersen PH, Sandberg S, Fraser CG, et al. (2001) Influenceof index of individuality on false positives in repeatedsampling from healthy individuals. Clin Chem Lab Med 39,160-165. (Pubitemid 32318481)
42. Iglesias N, Petersen PH & Ricos C (2005) Power functionof the reference change value in relation to cut-off points,reference intervals and index of individuality. Clin ChemLab Med 43, 441-448. (Pubitemid 41460652)
43. Westgard.com (2011) Biological variation database. http://westgard.com/ (accessed 14 September 2011).